Subject Matter Expert Network

Over the past 15 years, Alacrita has carefully assembled an extensive network of professional life science consultants, representing all key disciplines involved in the development and commercialization of drug products. These consulting associates typically bring 25+ years of experience in their respective fields and often specialize in specific therapy areas and product modalities.

What sets Alacrita apart is our capacity to build consulting teams with skills and experiences that precisely match the needs of our clients. Our specialists are built into our project teams and work on specific consulting assignments where they can contribute materially. We do not offer one-hour consults, which is something that sets our network apart.

Working with Alacrita, biotech companies can access the same caliber of expertise of a specialist consulting firm, but replicated across multiple disciplines in a single place. This allows us to support clients across a broad range of areas without any sacrifice in quality, while also permitting us to provide a multi-disciplinary and multi-stage perspective that can improve project results by delivering better strategic insight.

This structure allows Alacrita to work with a range of clients including pharmaceutical & biotech organizations of all sizes, including start-ups, virtual, growing and established companies, life science investors and selected academic institutions. Our consulting projects are typically issues-driven, can include both strategy and execution, and may involve individual consultants or multi-functional teams of experts.

Our consultants and network experts do not typically participate as respondents in surveys or market research reports.


Network Coverage

350+ specialist consultants spanning functional disciplines, therapeutic areas, and product modalities.

29
Functional Disciplines
18
Product Modalities
22
Therapeutic Areas

Click a category to explore

BD Licensing, Transactions, & Valuations
Biostatistics/Biometrics
Business Analysis/Forecasting
Business Plans/Investor Pitch
Clinical Operations
Clinical Quality Assurance
Clinical Strategy/Oversight
CMC-Manufacturing
CMC-Regulatory/Quality
Commercial Strategy/NPP
Discovery Biology
eCTD Regulatory Publishing
Intellectual Property
Market Access (P/R)
Marketing
Market Research
Medical Affairs
Medicinal Chemistry
Medical Monitoring/PV
Medical/Technical Writing
Pharmaceutical Development
Preclinical Pharmacology
Project/Program Management
Regulatory Affairs
Sales and Operations
Supply Chain – Clinical
Supply Chain – Commercial
Toxicology
Antibodies, ADCs
Biomarkers
Cell Therapy
Diagnostics
Drug Discovery Platforms
DNA/RNA
Drug Delivery Tech
Gene Therapy
Imaging Tools
Medical Devices
Medtech Software
Microbiome Drugs
Oncolytic Virus
Peptide/Protein Drugs
Radiopharmaceuticals
Small Molecules
Vaccines
Autoimmune/Immunology
Cardiovascular
Central Nervous System
Congenital Disorders
Dermatology/Aesthetics
Digestive/GI
Ear, Nose and Throat
Endocrine and Metabolic
Fibrosis
Genitourinary Diseases
Hematology
Infectious Disease
Inflammation/Pain
Injuries and Trauma
Musculoskeletal
Non-medical
Oncology
Ophthalmology
Orphan Diseases
Respiratory
Urology
Women's Health

Network Snapshot

75+
MDs Globally
Clinical development experts and CMO caliber leaders.
35+
Oncology MDs
Solid/liquid tumors, targeted therapies, immuno-oncology.
50+
Cell & Gene Therapy
Expertise across functional disciplines.
35+
Regulatory Affairs
US & European agency experience.
40+
CMC Experts
Across modalities and geographies.

Case Studies

Discover how Alacrita's expert network has helped companies navigate complex challenges and accelerate their development programs.


Learn More


Explore Working Together

Get in touch with our team to discuss how we work, learn more about our approach, or explore whether we might be a good fit for your needs.